Cargando…

Association of Serum Anti-PCSK9 Antibody Levels with Favorable Postoperative Prognosis in Esophageal Cancer

BACKGROUND: Esophageal cancer often appears as postoperative metastasis or recurrence after radical surgery. Although we had previously reported that serum programmed cell death ligand 1 (PD-L1) level correlated with the prognosis of esophageal cancer, further novel biomarkers are required for more...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ito, Masaaki, Hiwasa, Takaki, Oshima, Yoko, Yajima, Satoshi, Suzuki, Takashi, Nanami, Tatsuki, Sumazaki, Makoto, Shiratori, Fumiaki, Funahashi, Kimihiko, Li, Shu-Yang, Iwadate, Yasuo, Yamagata, Hiroki, Jambaljav, Byambasteren, Takemoto, Minoru, Yokote, Koutaro, Takizawa, Hirotaka, Shimada, Hideaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421770/ https://www.ncbi.nlm.nih.gov/pubmed/34504788 http://dx.doi.org/10.3389/fonc.2021.708039

Ejemplares similares

The combination of positive anti‑WDR1 antibodies with negative anti‑CFL1 antibodies in serum is a poor prognostic factor for patients with esophageal carcinoma
por: Ito, Masaaki, et al.
Publicado: (2023)

Serum WT1-271 IgM antibody as a novel diagnostic marker for Gastric Cancer
por: Ito, Masaaki, et al.
Publicado: (2022)

High serum PD‐L1 level is a poor prognostic biomarker in surgically treated esophageal cancer
por: Ito, Masaaki, et al.
Publicado: (2019)

Preoperative Low Serum Calcium Levels Predict Poor Prognosis for Patients with Esophageal Cancer
por: Shiratori, Fumiaki, et al.
Publicado: (2021)

Is High Score of Preoperative Lactate Dehydrogenase to Albumin Ratio Predicting Poor Survivals in Esophageal Carcinoma Patients?
por: Shiratori, Fumiaki, et al.
Publicado: (2023)

Diagnostic impact of high serum midkine level in patients with gastric cancer
por: Ito, Masaaki, et al.
Publicado: (2019)

Is high serum programmed death ligand 1 level a risk factor for poor survival in patients with gastric cancer?
por: Ito, Masaaki, et al.
Publicado: (2018)

Prevalence of serum galectin-1 autoantibodies in seven types of cancer: A potential biomarker
por: Nanami, Tatsuki, et al.
Publicado: (2021)

Randomized Phase II Study to Comparing Docetaxel/Nedaplatin versus Docetaxel for 5-Fluorouracil/Cisplatin Resistant Esophageal Squamous Cell Carcinoma
por: Yajima, Satoshi, et al.
Publicado: (2021)

Comparison between a new assay system, Elecsys(®) Anti-p53, and conventional MESACUP™ for the detection of serum anti-p53 antibodies: A multi-institutional study
por: Suzuki, Takashi, et al.
Publicado: (2022)

Utility of atherosclerosis-associated serum antibodies against colony-stimulating factor 2 in predicting the onset of acute ischemic stroke and prognosis of colorectal cancer
por: Li, Shu-Yang, et al.
Publicado: (2023)

Association between serum anti-ASXL2 antibody levels and acute ischemic stroke, acute myocardial infarction, diabetes mellitus, chronic kidney disease and digestive organ cancer, and their possible association with atherosclerosis and hypertension
por: Li, Shu-Yang, et al.
Publicado: (2020)

Serum anti-PCK1 antibody levels are a prognostic factor for patients with diabetes mellitus
por: Namiki, Toshiki, et al.
Publicado: (2023)

Serum anti‐LRPAP1 is a common biomarker for digestive organ cancers and atherosclerotic diseases
por: Sumazaki, Makoto, et al.
Publicado: (2020)

Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis
por: Li, Shu-Yang, et al.
Publicado: (2021)

Multipanel assay of 17 tumor‐associated antibodies for serological detection of stage 0/I breast cancer
por: Sumazaki, Makoto, et al.
Publicado: (2021)

Does Preoperative Low HbA1c Predict Esophageal Cancer Outcomes?
por: Kochi, Ryosuke, et al.
Publicado: (2019)

Pharmacokinetics and exploratory efficacy biomarkers of bococizumab, an anti-PCSK9 monoclonal antibody, in hypercholesterolemic Japanese subjects
por: Yokote, Koutaro, et al.
Publicado: (2019)

Elevation of autoantibody level against PDCD11 in patients with transient ischemic attack
por: Yoshida, Yoichi, et al.
Publicado: (2017)

Elevated levels of autoantibodies against DNAJC2 in sera of patients with atherosclerotic diseases
por: Yoshida, Yoichi, et al.
Publicado: (2020)

Possible predictive significance of serum RalA autoantibodies on relapse-free survival in patients with colorectal cancer
por: Ushigome, Mitsunori, et al.
Publicado: (2021)

Serum anti-SERPINE1 antibody as a potential biomarker of acute cerebral infarction
por: Kubota, Masaaki, et al.
Publicado: (2021)

Cell biology of diabetic nephropathy: Roles of endothelial cells, tubulointerstitial cells and podocytes
por: Maezawa, Yoshiro, et al.
Publicado: (2015)

Preoperative CRP(−)/CEA(−)/CA19-9(−)/non-T4 in Stage III Colorectal Cancer Is Favorable Risk for Recurrence
por: Ushigome, Mitsunori, et al.
Publicado: (2022)

Association of high proprotein convertase subtilisin/kexin type 9 antibody level with poor prognosis in patients with diabetes: a prospective study
por: Yamagata, Hiroki, et al.
Publicado: (2023)

Elevated Adiponectin Antibody Levels in Sera of Patients with Atherosclerosis-Related Coronary Artery Disease, Cerebral Infarction and Diabetes Mellitus
por: Hiwasa, Takaki, et al.
Publicado: (2016)

Favorable Effects of 24‐Week Whole-Body Vibration on Glycemic Control and Comprehensive Diabetes Therapy in Elderly Patients with Type 2 Diabetes
por: Kitamoto, Takumi, et al.
Publicado: (2021)

Helicobacter cinaedi infection in patients with diabetes: a case report
por: Ishibashi, Ryoichi, et al.
Publicado: (2015)

Autologous antibody to src-homology 3-domain GRB2-like 1 specifically increases in the sera of patients with low-grade gliomas
por: Matsutani, Tomoo, et al.
Publicado: (2012)

Role of Evaluating MGMT Status and 1p36 Deletion in Radiosurgery-Induced Anaplastic Ependymoma That Rapidly and Completely Resolved by Temozolomide Alone: Case Report and Review of the Literature
por: Hirono, Seiichiro, et al.
Publicado: (2015)

Real-time methylation-specific PCR for the evaluation of methylation status of MGMT gene in glioblastoma
por: Yoshioka, Masaki, et al.
Publicado: (2018)

Identification of Makorin 1 as a novel SEREX antigen of esophageal squamous cell carcinoma
por: Shimada, Hideaki, et al.
Publicado: (2009)

Elevation of Autoantibody in Patients with Ischemic Stroke
por: YOSHIDA, Yoichi, et al.
Publicado: (2018)

Effects of PCSK9 Inhibitor on Favorable Limb Outcomes in Patients with Chronic Limb-Threatening Ischemia
por: Sato, Yusuke, et al.
Publicado: (2021)

Circulating anti-filamin C autoantibody as a potential serum biomarker for low-grade gliomas
por: Adachi-Hayama, Masayo, et al.
Publicado: (2014)

Serum anti‑TSTD2 antibody as a biomarker for atherosclerosis‑induced ischemic stroke and chronic kidney disease
por: Kubota, Masaaki, et al.
Publicado: (2022)

Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke
por: Hiwasa, Takaki, et al.
Publicado: (2021)

Characteristic Clinical Features of Werner Syndrome with a Novel Compound Heterozygous WRN Mutation c.1720+1G>A Plus c.3139-1G>C
por: Matsumoto, Namiko, et al.
Publicado: (2018)

Continuous glucose monitoring reveals hypoglycemia risk in elderly patients with type 2 diabetes mellitus
por: Ishikawa, Takahiro, et al.
Publicado: (2017)

Association of serum levels of antibodies against MMP1, CBX1, and CBX5 with transient ischemic attack and cerebral infarction
por: Wang, Hao, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_epscdchsluefht5o9ojmna9l1c